T Marshall
Overview
Explore the profile of T Marshall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
304
Citations
2721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davis E, Martinez G, Blostein F, Marshall T, Jones A, Jansen E, et al.
J Dent Res
. 2021 Oct;
101(3):295-303.
PMID: 34609222
Dental caries (cavities), one of the most common infectious diseases, is caused by a number of factors. Oral microbes, dietary practices, sociodemographic factors, and dental hygiene all inform caries risk....
2.
Soreskog E, Borgstrom F, Shepstone L, Clarke S, Cooper C, Harvey I, et al.
Osteoporos Int
. 2020 Apr;
31(8):1499-1506.
PMID: 32239237
Introduction: The SCOOP (screening for prevention of fractures in older women) randomized controlled trial investigated whether community-based screening could reduce fractures in women aged 70-85 years. The objective of this...
3.
Condurache C, Chiu S, Chotiyarnwong P, Johansson H, Shepstone L, Lenaghan E, et al.
Osteoporos Int
. 2020 Jan;
31(3):457-464.
PMID: 31960099
Introduction: To investigate whether effectiveness of an osteoporosis screening programme to reduce hip fractures was mediated by modification of falls risk in the screening arm. Methods: The SCOOP study recruited...
4.
Parsons C, Harvey N, Shepstone L, Kanis J, Lenaghan E, Clarke S, et al.
Osteoporos Int
. 2019 Oct;
31(1):67-75.
PMID: 31606826
Introduction: In the SCreening of Older wOmen for Prevention of fracture (SCOOP) trial, we investigated the effect of the screening intervention on subsequent long-term self-reported adherence to anti-osteoporosis medications (AOM)....
5.
Hanton F, Chaudhary P, Doria D, Gwynne D, Maiorino C, Scullion C, et al.
Sci Rep
. 2019 Mar;
9(1):4471.
PMID: 30872656
Protontherapy has emerged as more effective in the treatment of certain tumors than photon based therapies. However, significant capital and operational costs make protontherapy less accessible. This has stimulated interest...
6.
Adderley N, Mallett S, Marshall T, Ghosh S, Rayman G, Bellary S, et al.
Diabet Med
. 2018 Feb;
35(6):798-806.
PMID: 29485723
Aim: To temporally and externally validate our previously developed prediction model, which used data from University Hospitals Birmingham to identify inpatients with diabetes at high risk of adverse outcome (mortality...
7.
Chandan J, Thomas T, Lee S, Marshall T, Willis B, Nirantharakumar K, et al.
J Thromb Haemost
. 2018 Jan;
16(3):474-480.
PMID: 29297977
Summary: Background Idiopathic thrombocytopenic purpura (ITP) is classically characterized by a transient or persistent decrease of platelet count. Mortality is higher in the ITP population than the general population, with...
8.
Stuart K, Adderley N, Marshall T, Rayman G, Sitch A, Manley S, et al.
Diabet Med
. 2017 Jun;
34(10):1385-1391.
PMID: 28632918
Aims: To explore whether a quantitative approach to identifying hospitalized patients with diabetes at risk of hypoglycaemia would be feasible through incorporation of routine biochemical, haematological and prescription data. Methods:...
9.
Jeddian A, Lindenmeyer A, Marshall T, Howard A, Sayadi L, Rashidian A, et al.
Int Nurs Rev
. 2017 May;
64(3):353-362.
PMID: 28555783
Aim: The aim of this study was to explore hospital staff perceptions of the perceived challenges and outcomes of implementing a critical care outreach service. Background: A nurse-led critical care...
10.
Toulis K, Hanif W, Saravanan P, Willis B, Marshall T, Kumarendran B, et al.
Diabetes Metab
. 2017 Mar;
43(3):211-216.
PMID: 28325589
Aim: The glucagon-like peptide-1 receptor agonist (GLP1a) liraglutide has been described to benefit patients with type 2 diabetes mellitus (T2DM) at high cardiovascular risk. However, there are still uncertainties relating...